Highlights
Analysis of the National Cancer Database (NCDB) shows that trachelectomy utilization peaked in 2016 and has since undergone a sustained decline, dropping from 64.0% of fertility-sparing procedures in 2011 to 33.3% in 2022. Longitudinal survival data confirms no significant difference in 10-year overall survival between patients undergoing trachelectomy and those receiving conization (93.4% vs. 92.3%, p=0.39). Bibliometric trends mirror clinical shifts, with academic output on trachelectomy peaking in 2021 before following a downward trajectory. These findings suggest a paradigm shift in gynecologic oncology toward surgical de-escalation for low-risk, early-stage cervical cancer.
Introduction: The Evolution of Fertility Preservation
For decades, radical trachelectomy—first popularized by Daniel Dargent in the late 1980s—stood as the gold standard for young women with early-stage cervical cancer who desired to preserve their fertility. By combining a radical resection of the cervix and parametria with pelvic lymphadenectomy, the procedure offered a middle ground between the curative intent of a radical hysterectomy and the reproductive aspirations of the patient. However, the procedure is technically demanding and associated with significant obstetric risks, including second-trimester miscarriage and preterm birth due to cervical insufficiency.
In recent years, the oncology community has questioned whether such radicality is necessary for all patients. The landmark ConCerv study in 2021 provided prospective evidence that less invasive approaches, such as conization or simple hysterectomy with nodal assessment, could be safely employed in carefully selected low-risk populations. As clinicians increasingly prioritize quality of life and obstetric outcomes alongside oncologic safety, the utilization of radical trachelectomy has come under scrutiny. This article interprets a comprehensive study by Levin et al., published in the American Journal of Obstetrics and Gynecology, which tracks the rise and fall of trachelectomy across three major national and academic databases.
Study Design and Methodological Rigor
The study utilized a multi-faceted approach to capture a holistic view of surgical trends and outcomes. Researchers integrated data from three distinct sources:
Clinical and Oncological Outcomes
Data from the National Cancer Database (NCDB) spanning 2004 to 2022 were used to identify 1,841 patients aged 18-45 with cervical cancer. The cohort was restricted to those managed with conservative surgery and nodal staging, divided into two groups: those undergoing trachelectomy and those undergoing conization.
Perioperative and Postoperative Safety
The ACS-NSQIP Participant Use Files (2012-2022) provided insights into surgical complications and short-term postoperative outcomes, ensuring that the shift in surgical choice was balanced against safety profiles.
Academic and Scholarly Output
A bibliometric analysis of the Web of Science Core Collection (2000-2025) was conducted to correlate clinical practice trends with the volume of scientific publications, providing a unique perspective on how research focus evolves in response to clinical evidence.
Statistical analysis included the use of Kaplan-Meier methods for overall survival, multivariable Cox regression adjusted for histology and tumor size, and annual percent change calculations for temporal trends. This robust methodology allows for a high degree of confidence in the observed shifts in practice patterns.
The Shifting Landscape: National Trends in Surgical Selection
The most striking finding of the study is the definitive decline in trachelectomy utilization. While the procedure saw a steady rise from the early 2000s, peaking in 2016, the subsequent years have seen a marked pivot. In 2011, trachelectomy accounted for 64.0% of fertility-sparing surgeries in the study cohort; by 2022, this figure had plummeted to 33.3%.
The data suggests that clinicians are increasingly opting for conization. This trend is likely driven by several factors. First, the demographic data showed that patients undergoing conization were slightly older (median age 33 vs. 31), and those undergoing trachelectomy were more likely to have adenocarcinoma (40.7% vs. 35.2%). However, even when accounting for these variables, the move toward less radical surgery is systemic. The number of lymph nodes examined was also higher in the trachelectomy group (15 vs. 10), reflecting the traditionally more aggressive surgical nature of the procedure.
Oncologic Equivalence: Survival Data Analysis
A primary concern for any surgical de-escalation is the potential for compromised oncologic outcomes. The study’s survival analysis provides significant reassurance. The 10-year overall survival (OS) was nearly identical between the two groups: 93.4% for trachelectomy and 92.3% for conization. The log-rank p-value of 0.39 indicates that this difference is not statistically significant.
Furthermore, multivariable Cox regression, which adjusted for stage, histology, surgical margins, and tumor size, yielded a hazard ratio of 1.02 (95% CI 0.56-1.86). This suggests that for node-negative cases, the radicality of the cervical resection (trachelectomy vs. conization) does not independently predict survival. This data aligns with the growing consensus that in low-risk cervical cancer—typically defined as tumors less than 2 cm with no lymphovascular space invasion—the risk of parametrial involvement is exceedingly low (often <1%), rendering radical parametrial resection unnecessary.
Academic Reflection: Bibliometric Trends
The study also highlights a fascinating correlation between clinical practice and academic interest. Bibliometric analysis identified 1,585 trachelectomy-related publications. Scholarly output peaked in 2021 with 128 publications and has since begun to decline. This peak in 2021 likely represents the culmination of research efforts following the publication of major trials like ConCerv. As the medical community reaches a consensus on the safety of less radical procedures, the focus of original research appears to be shifting toward optimizing conization techniques and improving obstetric outcomes in the post-conization population.
Expert Commentary: Navigating the Transition to Less Radicality
The decline of trachelectomy represents a classic example of evidence-based de-implementation. While radical trachelectomy was a revolutionary advancement in the 1990s, the current data suggests it may now be over-treatment for a significant subset of patients. The ConCerv study was a pivotal moment, providing the prospective validation that many surgeons needed to feel comfortable offering conization.
However, clinicians must remain cautious. The high overall survival observed in this study is contingent upon appropriate patient selection and thorough nodal staging. The fact that trachelectomy patients had more lymph nodes retrieved suggests that the thoroughness of the surgical staging may vary by procedure type. It is essential that as we move toward less radical cervical surgery, we do not compromise on the quality of nodal assessment, which remains a critical prognostic factor.
Another factor to consider is the “LACC Trial Effect.” Although the LACC trial focused on radical hysterectomy (showing worse outcomes for minimally invasive vs. open surgery), it prompted a broader re-evaluation of all surgical approaches in cervical cancer. This heightened scrutiny has likely contributed to the trend of choosing the most definitive yet least morbid “safe” option, which for many low-risk patients is now conization.
Conclusion: The Future of Fertility Sparing
The alignment of excellent survival outcomes with the decreasing use of trachelectomy underscores a successful transition toward tailored, less radical surgical care. For the clinician, this means that conization with nodal staging is increasingly the preferred fertility-sparing option for low-risk, early-stage cervical cancer. For the patient, this shift translates to lower surgical morbidity and potentially improved future pregnancy outcomes without a sacrifice in survival.
As we move toward 2030, research will likely continue to refine the boundaries of “low-risk” and further explore the role of sentinel lymph node mapping in conjunction with conservative cervical surgery. The decline of trachelectomy is not a sign of failure of the technique, but rather a sign of the maturation of gynecologic oncology as a field that can critically evaluate its own practices and evolve for the benefit of patient health.
References
1. Levin G, Gilbert L, Pareja R, et al. Trachelectomy in Decline: National Trends, Outcomes, and Academic Output Across Three Major Databases. American Journal of Obstetrics and Gynecology. 2026. PMID: 41791563.
2. Schmeler KM, Pareja R, Lopez Blanco A, et al. ConCerv: A prospective trial of conservative surgery for low-risk early-stage cervical cancer. International Journal of Gynecological Cancer. 2021;31(10):1317-1325.
3. Ramirez PT, Frumovitz M, Pareja R, et al. Minimally Invasive versus Open Radical Hysterectomy for Early Cervical Cancer. New England Journal of Medicine. 2018;379(20):1895-1904.
4. Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a fertility-preserving option for early cervical cancer. ACTA Obstetricia et Gynecologica Scandinavica. 2000;79(2):145-151.
